F. V. Gaalen

THU0370 CLUSTER-RANDOMIZED PRAGMATIC CLINICAL TRIAL EVALUATING THE POTENTIAL BENEFIT OF A TIGHT-CONTROL AND TREAT-TO-TARGET STRATEGY IN AXIAL SPONDYLOARTHRITIS: THE RESULTS OF THE TICOSPA TRIAL.

M. Dougados, A. Boonen, P. Claudepierre, 2020, Annals of the Rheumatic Diseases.

Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis.

F. Breedveld, R. Westendorp, R. Nelissen, 2003, Arthritis and rheumatism.

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.

F. Breedveld, W. Venrooij, F. Breedveld, 2004, Arthritis and rheumatism.

The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy

J. Maul, A. Schoepfer, S. Vavricka, 2018, Journal of Crohn's & colitis.

Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles

S. Cessie, F. Breedveld, S. le Cessie, 2005, Annals of the rheumatic diseases.

SAT0279 Patients fulfilling the imaging-arm and patients fulfilling the HLA-B27-arm of the asas axial spondyloarthritis classification criteria: Are they similar?

M. Reijnierse, T. Huizinga, D. Heijde, 2013 .

A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis

H. Visser, T. Huizinga, T W J Huizinga, 2005, Annals of the rheumatic diseases.

Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up Study.

D. M. van der Heijde, D. Hommes, H. Verspaget, 2016, Journal of Crohn's & colitis.